SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038076
Filing Date
2020-08-07
Accepted
2020-08-07 08:00:19
Documents
47
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20200630.htm   iXBRL 10-Q 1170180
2 EX-31.1 mack-ex311_6.htm EX-31.1 8725
3 EX-31.2 mack-ex312_7.htm EX-31.2 8726
4 EX-32.1 mack-ex321_8.htm EX-32.1 5641
5 EX-32.2 mack-ex322_9.htm EX-32.2 5639
  Complete submission text file 0001564590-20-038076.txt   3880732

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20200630.xsd EX-101.SCH 30811
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20200630_cal.xml EX-101.CAL 32690
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20200630_def.xml EX-101.DEF 74236
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20200630_lab.xml EX-101.LAB 231873
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20200630_pre.xml EX-101.PRE 166869
11 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20200630_htm.xml XML 600436
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 201083774
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences